16 February 2010
Simon Varcoe
Merck & Co has begun the first phase of a global restructuring programme, under which 15% of its total workforce will be axed.
The company hopes the initial phase of the programme will save it $2.6-3 billion annually by 2012, following the integration of Schering-Plough, which...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Sanofi results: Genzyme doesn't paper over cracks, as emerging markets top US and EU
- Revised deal with Depomed gives Santarus more control over US marketing of Glumetza
- Tekturna's future looks dim as Novartis cuts 1,960 jobs
- Stockwatch: A slimmer AstraZeneca starts to look tasty
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
